New Relic Revenue

In the year 2023, Finch Therapeutics Group had annual revenue of $107.00K, down -87.57%.

Revenue

107.00K

Revenue Growth

-87.57%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

19.98M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	107.00K	-754.00K	-87.57%
Dec 31, 2022	861.00K	-17.67M	-95.35%
Dec 31, 2021	18.53M	10.81M	140.08%
Dec 31, 2020	7.72M	-2.44M	-23.98%
Dec 31, 2019	10.15M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Veradigm	588.02M
Tian'an Technology Group	1.78M
Elite Pharmaceuticals	84.04M
Glass House Brands	215.62M
Northwest Biotherapeutics	1.47M
American Oncology Network	1.76B
Silence Therapeutics	27.17M
Global Cord Blood	196.10M

Revenue Rankings

Finch Therapeutics Group News

3 months ago - Arquitos Capital's Largest Holdings For Q1 2025 - Seeking Alpha
6 months ago - Finch Therapeutics: Post-Trial Decision Can Potentially Drive Shares To Trade Higher - Seeking Alpha
10 months ago - Finch Therapeutics looks to delist from the Nasdaq Global Select Market - Seeking Alpha
10 months ago - Finch Announces Delisting from Nasdaq and SEC Deregistration - GlobeNewsWire
2 years ago - Finch Announces Reverse Stock Split of Common Stock - GlobeNewsWire
2 years ago - Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates - GlobeNewsWire
2 years ago - Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women's Hospital and Updates to University of Minnesota License Agreement - GlobeNewsWire
2 years ago - Finch Therapeutics: Why This Finch Could Fly - An Asymmetric Risk/Reward Opportunity - Seeking Alpha

More News